Novel MCH₁ receptor antagonists: a patent review

Bibliography

• Chambers J, Ames RS, Bergsma D, et al. Melanin-concentrating hormone is the cognate ligand for the orphanG-protein coupled receptor SLC-1. Nature 1999;400:261-5
   PubMed Web of Science ®Google Scholar
• Macneil D. The role of melanin-concentrating hormone and its receptors in energy homeostasis. Front Endocrinol (Lausanne) 2013;4:1-14
   Google Scholar
• Chung S, Parks G, Lee C, Civelli O. Recent updates on the melanin-concentrating hormone (MCH) and its receptor system: lessons from MCH1R antagonists. J Mol Neurosci 2011;43:115-21
   PubMed Web of Science ®Google Scholar
• Högberg T, Frimurer T, Sasmal P. Melanin concentrating hormone receptor 1 (MCHR1) antagonists-Still a viable approach for obesity treatment? Bioorg Med Chem Lett 2012;22:6039-47
   Google Scholar
• Rivera G, Monge M, Bocanegra-Garcia V. Development of Melanin Concentrating Hormone Receptor R1 antagonists for the pharmacological treatment of obesity. Anti Obesity Drug Discov Dev 2011;1:200-28
   Google Scholar
• Johansson A. Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists. Expert Opin Ther Pat 2011;21:905-25
   PubMed Web of Science ®Google Scholar
• Bittencourt J, Presse F, Arias C, et al. The melanin concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 1992;319:218-45
   PubMed Web of Science ®Google Scholar
• Shimada M, Tritos N, Lowell B, et al. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 1998;396:670-4
   PubMed Web of Science ®Google Scholar
• Chung S, Parks G, Lee C, Civelli O. Recent updates on the melanin-concentrating hormone (MCH) and its receptor system: lessons from MCH1R antagonists. J Mol Neurosci 2011;43:115-21
   PubMed Web of Science ®Google Scholar
• Urbanavicius J, Lagos P, Torterelo P, Scorza C. Prodepressive effect induced by microinjections of MCH into the dorsal paphe: time course, dose dependence, efffects on anxiety-related behaviours and reversion by nortripyline. Behav Pharmacol 2014;25(4):316-24
   Google Scholar
• Audinot A, Della Zuana O, Fabry N, et al. S38151 [p-guanidinobenzoyl-[des-Gly10]-MCH(7-17)] is a potent and selective antagonist at the MCH1 receptor and has anti-feeding properties in vivo Peptides. 2009;30:1997-2007
   Google Scholar
• Della Zuana O, Audinot V, Levenez V, et al. Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity models. Front Endocrinol (Lausanne) 2012;3:1-13
   Google Scholar
• Ziogas D, Karagiannis A, Geiger B, et al. Inflammation-induced functional connectivity of melanin-concentrating hormone and IL-10. Peptides 2014;55:58-64
   Google Scholar
• Chee M, Pissios P, Prasad D, et al. Expression of melanin-concentrating hormone receptor 2 protects against diet-induced obesity in male mice. Endocrinology 2014;155(1):81-8
   Google Scholar
• Chen X, Mihalic J, Fan P, et al. Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2. Bioorg Med Chem Lett 2012;22:363-6
   PubMed Web of Science ®Google Scholar
• Ito M, Sakamoto M, Suzuki T, et al. Identification and characterization of a selective radioligand for melanin concentrating hormone 1-receptor (MCH1R). Bioorg Med Chem Lett 2009;19:2835-9
   PubMed Web of Science ®Google Scholar
• Philippe C, Schirmer E, Mitterhauser M, et al. Radiosynthesis of [11C]SNAP-7941 – the first PET-tracer for the melanin concentrating hormone receptor 1 (MCHR1). Appl Radiat Isot 2012;70:2287-94
   Google Scholar
• Philippe C, Nics L, Zeilinger M, et al. Preclinical in vitro & in vivo evaluation of [11C]SNAP-7941 – the first PET tracer for the melanin concentrating hormone receptor 1. Nucl Med Biol 2013;40(7):919-25
   Google Scholar
• Philippe C, Hausler D, Fuchshuber F, et al. Comparative autoradiographic in vitro investigation of melanin concentrating hormone 1 receptor ligands in the central nervous system. Eur J Pharmacol 2014;735:177-83
   Google Scholar
• Borowsky B, Durkin M, Ogozalek M, et al. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med 2002;8:825-83
   PubMed Web of Science ®Google Scholar
• Available from: http://www.astrazeneca.com/Research/Our-pipeline-summary; As of 31 July 2014
   Google Scholar
• Anderson A, Storz T, Liu P, et al. Stereoselective synthesis of a MCHr1. Antagonist J Org Chem 2007;72:9648-55
   Google Scholar
• See reference 2, which summarizes known pieces of information
   Google Scholar
• Washburn W, Manfredi M, Devasthale P, et al. Evolution of nonbasic thienopyrimidinone containing alcohols as selective MCHR1 antagonists culminating in the discovery of the clinical candidate BMS-830216 [MEDI-17]. Abstracts of Papers, 244th ACS National Meeting & Exposition; 19 – 23 August 2012; Philadelphia, PA, USA
   Google Scholar
• Moore N, Sargent B, Guzzo P, Surman M. From preclinical to clinical development: the example of a novel treatment for obesity. Neurobiol Dis 2014;61:47-54
   Google Scholar
• Stubbs R, Hughes D, Johnstone MA, et al. The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br J Nutr 2000;84:405-15
   PubMed Web of Science ®Google Scholar
• Inflammatory bowel disease
   Google Scholar
• Washburn W, Manfredi M, Devasthale P, et al. Identification of a non-basic Melanin Concentrating hormone receptor 1 antagonist as an antiobesity clinical candidate. J Med Chem 2014;57:7509-22
   Google Scholar
• An overview of the observed findings are given on. Available from: http://www.ncats.nih.gov/files/BMS-830216.pdf.pdf
   Google Scholar
• Albany Molecular Research, Inc. Preparation of azinone-substituted azepinoindole derivatives as MCH-1 receptor antagonists and use in the treatment of diseases. WO003005; 2011
   Google Scholar
• Albany Molecular Research, Inc. Preparation of (azabicycloalkyl)indole and (azabicycloalkyl)pyrrolopyridine derivatives as MCH-1 receptor antagonists and use in the treatment of diseases. WO003007; 2011
   Google Scholar
• Albany Molecular Research, Inc. Preparation of azinone-substituted azapolycycles as MCH-1 receptor antagonists and use in the treatment of diseases. WO003012; 2011
   Google Scholar
• Albany Molecular Research, Inc. Preparation of azinone-substituted (azabicycloalkyl)indoles and (azabicycloalkyl)pyridoindoles as MCH-1 receptor antagonists and use in the treatment of diseases. WO003021; 2011
   Google Scholar
• Albany Molecular Research, Inc. Preparation of tetrahydro-azacarboline MCH-1 antagonists. US157460; 2012
   Google Scholar
• Albany Molecular Research, Inc. Preparation of piperazinone-substituted tetrahydro-carboline MCH-1 antagonists. US0157469; 2012
   Google Scholar
• AstraZeneca. Therapeutic agents 713. WO125390; 2010
   Google Scholar
• AstraZeneca. Therapeutic agents 976. WO004588; 2012
   Google Scholar
• AstraZeneca. New substituted (3-(4-(spiroheterocyclic)methyl)phenoxy)-azetidin-1-yl)(5- (phenyl)-1,3,4-oxadiazol-2-yl)methanone compounds are melanin-concentrating hormone receptor protein 1 modulators useful to treat or prevent e.g. obesity and anxiety. WO011285; 2013
   Google Scholar
• Boehringer Ingelheim. Pyridinone and pyridazinone derivatives as MCH-receptor modulators and their preparation. WO131935; 2013
   Google Scholar
• Bristol Myers Squibb. New substituted 1H-pyrazin-2-one compounds are melanin-concentrating hormone receptor 1 antagonists useful to treat e.g. obesity, diabetes, arteriosclerosis, hypertension, polycystic ovary disease, cardiovascular disease, osteoarthritis. US0003759; 2011
   Google Scholar
• Bristol Myers Squibb. New substituted benzene compounds are melanin concentrating hormone receptor-1 modulators, useful to treat e.g. obesity, diabetes, depression, anxiety, sleep disorders and psychiatric disorders such as schizophrenia and substance abuse. US0034375; 2011
   Google Scholar
• Bristol Myers Squibb. Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists. WO039411; 2014
   Google Scholar
• Bristol Myers Squibb. Pyrrolones and pyrrolidinones as melanin concentrating hormone receptor-1 antagonists and their preparation. WO039412; 2014
   Google Scholar
• GlaxoSmithKline. Bis-pyridylpyridones as melanin concentrating hormone receptor 1 antagonists. WO076387; 2009
   Google Scholar
• GlaxoSmithKline. Preparation of bis-pyridylpyridones as melanin-concentrating hormone receptor 1 (MCHR1) antagonists. WO141538; 2010
   Google Scholar
• Souers A, Wodka D, Gao J, et al. Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 1. Bioorg Med Chem Lett 2004;14:4873-7
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKline. Preparation of bispyridylpyridones as melanin-concentrating hormone receptor 1 antagonists for treatment of diabetes and obesity. WO141539; 2010
   Google Scholar
• GlaxoSmithKline. Preparation of bis-pyridylpyridones as melanin-concentrating hormone receptor 1 (MCHR1) antagonists. WO141540; 2010
   Google Scholar
• GlaxoSmithKline. Preparation of spirocyclyl bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists for treatment of obesity and diabetes. WO141545; 2010
   Google Scholar
• GlaxoSmithKline. Preparation of dihydronaphthalenylpyridone derivatives for use as melanin-concentrating hormone receptor 1 antagonists. WO149362; 2013
   Google Scholar
• GlaxoSmithKline. Preparation of dihydronaphthalenylpyridone derivatives for use as melanin-concentrating hormone receptor 1 antagonists. WO166621; 2013
   Google Scholar
• Korea Research Institute. Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same. WO08140239; 2008
   Google Scholar
• Korea Research Institute. Preparation of 2-substituted 6-(biphenyl-4-carboxamido)quinoxaline derivatives as MCH1R inhibitors. KR094573A; 2011
   Google Scholar
• Korea Research Institute. Preparation of 1-(6,7-difluoro-3-methoxyquinoxalin-2-yl)-3-[1- (heteroarylmethyl)piperidin-4-yl]urea derivatives as MCH1R inhibitors. KR094566A; 2011
   Google Scholar
• Korea Research Institute. 1,2,4-Oxadiazole derivative as MCH receptor antagonist and method for the preparation thereof. KR017856A; 2012
   Google Scholar
• Korea Research Institute. 5,6-Dihydro-pyrrolo[3,4-b]pyridin-7-one derivative as MCH receptor-1 antagonist and method for the preparation thereof. KR038039A; 2012
   Google Scholar
• Korea Research Institute. Preparation of pyrrolopyridinone derivatives as MCH receptor-1 antagonists. KR103243A; 2012
   Google Scholar
• Lim CJ, Kim JY, Lee BH, et al. Synthesis and SAR study of pyrrolo[3,4-b]pyridin-7(6H)-one derivatives as melanin concentrating hormone receptor 1 (MCH-R1) antagonists. Bioorg Med Chem Lett 2013;23:1736-9
   Google Scholar
• Korea Research Institute. Phthalazinone derivative containing aryl-piperidine moiety as MCH (melanin-concentrating hormone) receptor antagonist and method for the preparation. KR0034829A; 2012
   Google Scholar
• Lim CJ, Kim SH, Lee BH, et al. 4-Arylphtalazin-1(2H)-one derivatives as potent antagonists of the melanin concentrating hormone receptor 1 (MCH-R1). Bioorg Med Chem Lett 2012;22:427-30
   Google Scholar
• Korea Research Institute. Phthalazinone derivative containing 5-membered heteroaryl moiety as MCH receptor antagonist and method for the preparation thereof. KR037720A; 2012
   Google Scholar
• Korea Research Institute. Preparation of phthalazinone derivative as MCH receptor-1 antagonist and preparation method thereof. KR042847A; 2013
   Google Scholar
• Lim CJ, Lee HI, Kim N, et al. 4-Aminophtalazin-1(2H)-one Derivatives as Melanin Concentrating Hormone Receptor 1 (MCH-R1) Antagonists. Bull Korean Chem Soc 2013;34(12):3851-4
   Google Scholar
• Korea Research Institute. Preparation of benzofuran-2-carboxamide derivatives as MCH receptor-1 antagonists. KR103220A; 2012
   Google Scholar
• Korea Research Institute. Preparation of naphtho[1,2-b]furan-2-carboxamide derivative as MCH receptor-1 antagonist and preparation method thereof. KR042846A; 2013
   Google Scholar
• Lim CJ, Choi JY, Lee BH, et al. Synthesis and structure-activity relationship of naphto[1,2-b]furan-2-carboxamide derivatives as melanin concentrating hormone receptor 1 antagonists. Chem Pharm Bull (Tokyo) 2013;61(12):1239-47
   Google Scholar
• Lim CJ, Kim N, Lee EK, et al. Synthesis and SAR investigations of novel 2-arylbenzimidazole derivatives as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists. Bioorg Med Chem Lett 2011;21:2309-12
   Google Scholar
• Merck Sharpe & Dohme. Preparation of pyridone derivatives for use as melanin concentrating hormone receptor antagonists. WO127643A1; 2011
   Google Scholar
• Merck Sharpe & Dohme. Pyridone derivatives as therapeutic agents. WO130086A1; 2011
   Google Scholar
• Merck Sharpe & Dohme. Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism. WO037771A1; 2011
   Google Scholar
• Gedeon Richter. New oxetane substituted thieno-pyrimidinone compounds are melanin concentrating hormone receptor 1 antagonists, useful for treating e.g. obesity, diabetes, metabolic disorder, bulimia, mood disorders, anxiety and depression. WO153154A1; 2012
   Google Scholar
• Shionogi. Preparation of condensed heterocyclic compounds as MCH (melanin-concentrating hormone) receptor antagonists. WO36233; 2012
   Google Scholar
• Taisho Pharmaceutical Co. 7-Piperidinoalkyl-3,4-dihydroquinolone derivative. WO038901; 2010
   Google Scholar
• Taisho Pharmaceutical Co. Preparation of 7-piperidinoalkyl-3,4-dihydroquinolone compounds as MCH (melanin concentrating hormone) receptor antagonists. JP219467A; 2011
   Google Scholar
• Takeda. Preparation of indole derivatives as melanin concentrating hormone (MCH) receptor antagonists. WO083804A1; 2011
   Google Scholar
• Takeda. Condensed aromatic compounds as melanin-concentrating hormone receptor antagonists and pharmaceuticals containing them for inhibiting appetite and treating obesity. WO168760A1; 2013
   Google Scholar
• Takeda. Preparation of 2,5-disubstituted furo[3,2-c]pyridin-4(5H)-one compounds as MCHR (melanin-concentrating hormone receptor) antagonists. WO168759A1; 2013
   Google Scholar
• Takeda. Preparation of benzimidazole and imidazopyridine derivatives and analogs as MCH receptor antagonists for treating obesity. WO105676A1; 2013
   Google Scholar
• Mihalic JT, Chen X, Fan P, et al. Discovery of a novel series of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. Biorg Med Chem Lett 2011;21:7001-5
   Google Scholar
• Kasai S, Kamata M, Masada S, et al. Synthesis, structure-activity relationship, and pharmacological studies of novel Melanin-Concentrating Hormone receptor 1 antagonists 3-Aminomethylquinolines: reducing human Ether-a-go-go-related gene (hERG) associated liabilities. J Med Chem 2012;55:4336-51
   Google Scholar
• Hertzog DL, Al-Barazanji KA, Barvian KK, et al. MCHr1 antagonists: problems and solutions. Abstracts of Papers, 240th ACS National Meeting MEDI-283; 22 – 26 August 2010; Boston, MA, USA
   Google Scholar